Pfizer developing COVID booster shot to protect against Delta variant

Pfizer announced Thursday that it is developing a booster shot to fight the highly contagious Delta variant of COVID-19 — as fears mount over the US’ most dominant strain, according to a report.

The drug making firm and its partner, BioNTech, said adding a third jab to the two-dose vaccination could provide the “highest levels” of protection against all variants, including the Delta, CNBC reported.

“As seen in real world evidence released from the Israel Ministry of Health, vaccine efficacy has declined six months post-vaccination, at the same time that the Delta variant is becoming the dominate variant in the country,” the companies told the outlet.

“These findings are consistent with an ongoing analysis from the companies’ Phase 3 study,” the statement said. “That is why we have said, and we continue to believe that it is likely, based on the totality of the data we have to date, that a third dose may be needed within 6 to 12 months after full vaccination.”

Cynical trials for the booster shot could start as early as August and are subject to regulatory approvals, the outlet reported.

Delta variant makes up majority of US COVID cases for first time: CDC Executives from both firms have said in the past that people will likely need a third dose within a year of getting fully vaccinated.

The Delta variant, which was first reported in India, became the most dominant COVID-19 variant in the US on Wednesday, accounting for 51.7 percent of cases.

1947 The British Medical Research Council begins testing 50,000 children in Britain with the Pertussis vaccine. All children tested are more than 14 months old (not newborns). Eight infants had convulsions within 72 hours of the shot, 34 had convulsions within 28 days of the shot. British doctors denied a connection between the vaccine and the convulsions, declaring the tests a success and began administering it to all British children.

Despite the fact that none of the tests were conducted on children under 14 months old (newborns & babies), the United States holds the tests in evidence that the vaccine is safe for newborns as young as 6 weeks of age. The testing would continue until 1957.

1948 Randolph K. Byers and Frederick C. Moll of the Harvard Medical School publish an article describing children who had suffered brain damage after receiving Pertussis vaccine. The findings provided the first clear evidence that the vaccine caused the serious neurological complications in children.

1948 Randolph Byes and Frederick Moll of Harvard Medical School validate that severe neurological disorders follow the administration of DPT vaccine. The research was performed at Children’s Hospital in Boston and published in Pediatrics magazine. Nothing was done by physicians to halt the use of DPT vaccine.

1948 A study on Pertussis vaccine reaction is done by Randolph K. Byers and Frederick C. Moll of the Harvard Medical School. They examine 15 children who had reacted violently within 72 hours of a Pertussis vaccination. All the children were normal before the shot. None had ever had a convulsion before. One of the children became blind, deaf, spastic and helpless after being given the Pertussis shot. Out of the 15 children, 2 died and 9 suffered from damage to their nervous system. Physicians were displeased by these results.

1948 England bans smallpox vaccine.

1948 North Carolina polio cases number 2,498. See 1949.

1948 Louis Sauer makes an interesting observation at an AMA meeting where Pertussis vaccination was discussed. Louis Sauer points out that ‘the neurological damage caused by Pertussis vaccine is the same as the damage caused by Pertussis (whooping cough–Which is logical, because they use the bacteria in the vaccine). According to Sauer, ‘a customary prophylactic dose of Pertussis vaccine seems to illicit a chain of nervous system reactions and in some cases irreversible pathological changes in the brain. These findings resemble those encountered in cases of severe whooping cough (Pertussis).’ In other words, the vaccine is causing the disease condition.

1949 US Public Health Service Division of Biologics Standards establish a national potency test for Pertussis vaccine, and modify it in 1953 to establish potency limits. Despite this, the Pertussis vaccine that is pronounced ‘safe’ still causes minimal brain damage (MBD) in humans.

1951 Theiler wins Nobel for work on yellow fever vaccine.

1952 Formulation of the polio vaccine begins. Tens of millions of doses of polio vaccines produced from virus grown in monkey cells infected with SV-40 (Simian Virus #40). Scientists ‘perform experiments in laboratories to determine the correct doses of antigen and supplementary chemicals to use in the polio
vaccine. (Ironically, since the scientific premise of vaccination is faulty, a ‘correct dose of antigen and chemicals’ does not exist).

1953 At the University of Zurich, Dr. S.Kong of the Pediatric Clinic compiles a list of 82 cases of Pertussis vaccine damage from world literature.

1953 The Swedish conduct a study on the Pertussis vaccine. Anna L. Annell, a Swedish researcher, writes a major work on Pertussis which indicates that ‘pertussis vaccine may be associated with the most varying kinds of cerebral complications which may be cortical, subcortical or peripheral.’

Encephalitis after vaccination is known to produce the same range of disabilities and impairment. Annel also wrote, ‘during the past few decades certain of the epidemic children’s disease, measles in particular, have shown an increased tendency to attack the central nervous system. After the 1920’s a large number of cases involving CNS damage were reported.

1954 Salk vaccine begins to be given to school children in Philadelphia.

1954 Parke-Davis pharmaceutical company combines the DPT shot with Polio vaccine. The new combination of four vaccines is called Quadrigen. (See 1959).

1954 Reward of $30,000 offered to anyone who proves polio vaccine not a fraud. Not one person was able to claim the reward.

1954 Mrs. Oveta Culp Hobby, Secretary of Health, Education and Welfare, allows a press photo to be taken during a ceremony declaring Salk vaccine safe.

1954 Polio rate caused by the vaccine accelerates ten-fold in Massachusetts.

1954 Eli Lilly company begins renovation of a five-story building in Indianapolis in July 1954 for the production of Salk vaccine. It is in full production by October of

1954. Wyeth, Parke-Davis and others follow suit.

1954 A study on ‘neurologic sequelae of prophylactic innoculation’ summarized state-of-the-art knowledge in noting that the common factor in the pathology of encephalitis from vaccination is ‘anaphlactic hypersensitivity’.

1955 Georgia State public health officers meet in Atlanta (May 1955) to discuss what was going wrong with the Salk vaccine program. A U.S. Public Health scientist at the meeting told the group that ‘he was not permitted to disclose what had happened because it would jeopardize the investment of the pharmaceutical firms in the vaccine program.’

1955 Measles death rate has naturally declined, without vaccines, to .03 per 100,000 by 1955.

1955 At the University of Illinois School of Medicine, Department of Neurology, Niels Low shows that the EEG of infants is sometimes altered by a DPT shot,concluding that significant cerebral reactions and neurological changes occur.

1955 American Cancer Society advertising circular states ‘cancer will strike one of every four persons now living. More children from 3 to 15 years of age die of cancer than from any other disease.’ (50 years before, cancer was unheard of in children). According to the ACS, they are predicting 6.4 million deaths from cancer, compared with 128,000 in 1933–an increase of 6.2 million cases in 22 years. Vaccination, pesticide use and chemical pollution are the main factors that have increased since 1933.

1955 Despite the sky rocketing cases of vaccine-induced polio, the AMA, NFIP and USPHS claim a reduction of 40-50%.

1955 Idaho brings its Salk vaccination program to a halt on July 1, 1955.

Utah does the same on July 12, 1955.

1955 Boston Herald newspaper reports on April 18, 1955, features an article entitled ‘Drug Companies Expecting Big Profit on Salk Vaccine’, which stated. ‘A spokesman for Parke-Davis, which made 50% of the Salk vaccine, said ‘now that it has been declared safe, we can get back the millions we invested in the development of the Salk vaccine and make a profit out of it. Our company will made over $10 million on Salk vaccine in 1955.’

1955 Rhodes and Company, Wall Street brokers specializing in drug securities, estimate that the gross revenue of the six vaccine houses licensed to produce and sell Salk vaccine would be about $60 million, with profits of $20 million.

1955 The CIA conducts a biological warfare experiment in the Tampa Bay area in Florida with agents withdrawn from an Army CBW center. A sharp rise in whooping cough (Pertussis) cases occurs, including 12 deaths, following the test.

1955 Washington Bureau of the Detroit Free Press reports, on June 3, 1955, that ‘The USPHS reported that more children who received Salk shots made by the Wyeth Labs suffered polio more than could normally be expected;’

1955 AMA Conference in Atlantic City, New Jersey. Article by James C. Spaulding who covered the conference was published in the AMA Journal, June 19,

1955, ‘A policy of secrecy and deception has been followed by the National Foundation for Infantile Paralysis and the US Public Health Service in the polio vaccine programs. The nation’s physicians were prevented from learning vital information about the trouble with Salk vaccine. The US Public Health Service had an advisory group made up almost entirely of scientists who were receiving money from the National Foundation of Infantile Paralysis, which was exerting pressure to go ahead with the program even after Salk vaccine was found to be dangerous.’ Spaulding further said, ‘the Infantile Paralysis Foundation kept secret the fact that live virus was detected in four out of six supposedly ‘finished and safe’ lots of vaccine.’

1955 Salk Polio Vaccine again used in the US. Cases of polio skyrocket again in the United States.

1955 Reported that doctors on the staff of the National Institutes for Health are avoiding vaccination of their children with the Salk vaccine, and that after experimenting with 1200 monkeys, they declared the Salk vaccine worthless as a preventative and a danger to take.

1955 First vaccinated generation become adolescents.

1955 Massachusetts reports 642% increase in polio since vaccinations began in 1954 with vaccination of 130,000 children. In response, the National Foundation for Infantile Paralysis states that the increase in cases was due to the fact that ‘no children were vaccinated there.’

1955 Massachusetts bans the sale of Salk vaccine.’

1955 Dr. Graham W. Wilson, director of Britain’s Public Health Laboratory Service, who knew about the NIH Salk vaccine trials, says ‘I do not see how any vaccine prepared by Salk’s method can be guaranteed safe.’

1955 US Surgeon General Scheele admits in a closed session of the AMA that ‘Salk polio vaccine is hard to make and no batch can be proven safe before given to children’. Despite this fact, the public is told that the vaccine is safe. The government announces that it has the intention to vaccinate 57 million people before August 1955.

1955 Surgeon General Scheele (who never practiced medicine a day in his life!) goes on public radio saying ‘I have complete confidence in the Salk vaccine. I urge doctors to continue vaccinations.’

1956 Seventeen states in the United States reject their government-supplied Salk polio vaccine.

1956 US government appropriates $53.6 million to ‘aid states in providing free vaccine to people under 20 years of age’.

1956 Idaho health director Peterson states that polio only struck vaccinated children in areas where there had been no cases of polio since the preceding autumn. In 90% of the cases, the paralysis occurred in the arm in which the vaccine had been injected.

1956 American Public Health Service announces 168 cases of polio and 6 deaths among those vaccinated. Censorship is then imposed on the reporting of reactions to Salk vaccine.

1956 Oral polio vaccine developed further by Sabin.

1956 The US Public Health Service and the National Foundation for Infantile Paralysis (Rockefeller) put on a drive to ‘sell’ Salk polio vaccine to the public.

1957 Governor Knight of California asks the legislature for $3 million in order to insure vaccination for all those under 40 years old with Salk polio vaccine. The newspapers report that corporate profits from the Salk vaccine will be in excess of $5 billion. (Feb 6, 1957). Governor Knight notes there are 4 million Californians under 40 and signs the bill.

Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.